📍Recalling firmLupin Pharmaceuticals Inc.Harborplace Tower, 111 S Calvert St Fl 21st · Baltimore, MD 21202-6174
✎ GovInfoNow plain-language explainer
Lupin Pharmaceuticals Inc. is recalling one lot of Cefixime for Oral Suspension (100mg/5mL) because it contains failed impurities or degradation products that exceed specification limits. The recall affects 4,608 bottles distributed nationwide in the USA. Consumers should check their medication against the specific lot number provided. Read more at govinfonow.com/recall/32893-lupin-recalls-cefixime-oral-suspension-due-to-impurities.
“Lupin Recalls Cefixime Oral Suspension Due to Impurities.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/32893-lupin-recalls-cefixime-oral-suspension-due-to-impurities. Based on FDA recall #D-0274-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0274-2024%22&limit=1).
The FDA announced on Jan. 3, 2024, that Lupin Pharmaceuticals Inc. voluntarily recalled Cefixime for Oral Suspension due to failed impurities and degradation specifications. The recall affects 4,608 bottles distributed nationwide.
How to tell if you have it
Brand: Lupin Pharmaceuticals
Product: Cefixime for Oral Suspension 100mg/5mL
Packaging: 50 mL bottle, Rx Only
NDC: 68180-405-01
Lot #: F304833
Expiration: 06/2025
The hazard
The product failed impurities and degradation specifications, according to the FDA. The recall is classified as a Class II hazard.
Context
GovInfoNow's records show Lupin Pharmaceuticals Inc. has had 90 other recalls since Jan. 31, 2013. Recent brand recalls include a Clobetasol Cream recall on Aug. 3, 2026, for failed content uniformity and a Glucagon Emergency Kit recall on June 23, 2026, due to CGMP deviation risks. Other recent recalls of similar products include Sun Pharmaceutical's Fluocinolone Acetonide Solution recall (Dec. 30, 2025), Rising Pharma's Temozolomide capsules recall (March 3, 2026), and QuVa Pharma's Methohexital Sodium recall (June 24, 2026).
How to tell if you have this one
Look for a 50 mL bottle of Cefixime for Oral Suspension 100mg/5mL manufactured by Lupin Pharmaceuticals Inc. The specific recalled item has NDC 68180-405-01 and Lot # F304833 with an expiration date of 06/2025.
Brand
Lupin Pharmaceuticals
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Medication
Verify if your bottle matches NDC 68180-405-01 and Lot # F304833 with an expiration date of 06/2025.
Contact Your Pharmacist
Speak with your healthcare provider or pharmacist to determine the appropriate next steps for this specific lot.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 12 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0274-2024 (January 3, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0274-2024 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.